• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Mayne Pharma

anonymous board for Mayne Pharma
Replies
50
Views
36K
anonymous
Replies
4
Views
2K
anonymous
Replies
0
Views
570
anonymous
Replies
23
Views
12K
anonymous
Replies
0
Views
1K
anonymous
Replies
3
Views
2K
anonymous
2
Replies
0
Views
1K
anonymous
Replies
0
Views
4K
anonymous
Replies
7
Views
7K
anonymous
Replies
1
Views
4K
anonymous